Product Information
BETAXOLOL HCL 0.5% EYE DROP is a generic product labeled by Sandoz Inc., priced at $8.9624 per ML under NDC 61314024501. Its NADAC has been published 584 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 1985. Its Orange Book therapeutic-equivalence code is AT.
Strength
5.6 mg/mL
Manufacturer
Sandoz Inc.NDC
61314024501
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BETAXOLOL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019270FDA Approved
8/30/1985
TE Code
AT
On Market Since
5/15/2000
Pharmacological Classes
Price Statistics
The NADAC for BETAXOLOL HCL 0.5% EYE DROP has been published 584 times since Nov 28, 2013, and over the history we have for it it has declined 10.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9624 per ML |
|---|---|
| All-time high | $10.4373 (Jun 11, 2014) |
| All-time low | $8.1287 (Aug 21, 2024) |
| 52-week high | $8.9624 |
| 52-week low | $8.4532 |
| Median price | $8.8549 |
| Average price | $9.1423 |
| Largest weekly change | +14.6% (Aug 17, 2016) |
| Weeks tracked | 584 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betaxolol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAXOLOL HCL 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BETAXOLOL HCL 0.5% EYE DROP, manufactured by Sandoz Inc., is $8.9624 per ML (NDC 61314024501), effective Sep 30, 2026.
How has the price of BETAXOLOL HCL 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BETAXOLOL HCL 0.5% EYE DROP has declined 10.0%. It has been tracked across 584 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETAXOLOL HCL 0.5% EYE DROP?
Since Nov 28, 2013, the NADAC for BETAXOLOL HCL 0.5% EYE DROP has ranged from a low of $8.1287 (Aug 21, 2024) to a high of $10.4373 (Jun 11, 2014), with a median of $8.8549 per ML.
Are there cheaper alternatives to BETAXOLOL HCL 0.5% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BETAXOLOL HCL 0.5% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures BETAXOLOL HCL 0.5% EYE DROP?
BETAXOLOL HCL 0.5% EYE DROP (NDC 61314024501) is labeled by Sandoz Inc., and CMS classifies it as a generic product.